HVCN1 and neoplasm: Recently, the presence of Hv1 channels in T lymphocytes, and that loss of Hv1 in T lymphocytes leads to a metabolic reprogramming and an impaired activation of T lymphocytes that could affect their priming stage, possibly affecting their anti-tumor response (Coe et al., 2022).